Treatment of Hypersexuality and Disinhibited Sexual Behavior in Huntington's Disease When Social Discomfort or Violence Is Present

Clinical scenario

In Huntington's disease, sexual dysfunction can take several forms. While decreased libido is the most frequent, hypersexuality or disinhibited sexual behavior — particularly when it causes social discomfort or involves violence — represents a rarer but clinically significant presentation that requires a structured, evidence-informed approach.

Specific situation

This protocol addresses Huntington's disease patients exhibiting hypersexuality or sexually disinhibited conduct that extends to social discomfort or violent behavior. Managing this presentation involves coordinating pharmacological intervention with a behavioral and psychological component aimed at restoring appropriate conduct within the patient's social setting.

Treatment approach (overview)

First-line management combines a targeted pharmacological intervention with a behavioral-psychological strategy. The behavioral component focuses on re-establishing appropriate standards of behavior.

The complete regimen — specific agents, how they are combined, and the full behavioral framework — is available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3389/fneur.2019.00710

Decreased libido is the most common symptom while hypersexuality or disinhibited behavior are rarer, but can cause significant problems in relationships.

If hypersexuality involves social discomfort or violence, the proposed first-line treatment is a neuroleptic (Grade C) and/or a SSRI.

A behavioral and psychological approach is useful in the case of hypersexuality, by re-establishing appropriate standards of behavior in the patient's social setting.

View source ↗